Unknown

Dataset Information

0

Comprehensive Identification of Potential Crucial Genes and miRNA-mRNA Regulatory Networks in Papillary Thyroid Cancer.


ABSTRACT:

Background

Thyroid cancer is the most common endocrine malignancy, with a recent global increase of 20% in age-related incidence. Ultrasonography and ultrasonography-guided fine-needle aspiration biopsy (FNAB) are the most widely used diagnostic tests for thyroid nodules; however, it is estimated that up to 25% of thyroid biopsies are cytologically inconclusive. Molecular markers can help guide patient-oriented and targeted treatment of thyroid nodules and thyroid cancer.

Methods

Datasets related to papillary thyroid cancer (PTC) or thyroid carcinoma (GSE129562, GSE3678, GSE54958, GSE138042, and GSE124653) were downloaded from the GEO database and analysed using the Limma package of R software. For functional enrichment analysis, the Kyoto Encyclopedia of Genes and Genomes pathway analysis and Gene Ontology were applied to differentially expressed genes (DEGs) using the Metascape website. A protein-protein interaction (PPI) network was built from the STRING database. Gene expression, protein expression, immunohistochemistry, and potential functional gene survival were analysed using the GEPIA website, the Human Protein Atlas website, and the UALCAN website. Potential target miRNAs were predicted using the miRDB and Starbase datasets.

Results

We found 219 upregulated and 310 downregulated DEGs, with a cut-off of p < 0.01 and ?log?FC | >1.5. The DEGs in papillary thyroid cancer were mainly enriched in extracellular structural organisation. At the intersection of the PPI network and Metascape MCODEs, the hub genes in common were identified as FN1, APOE, CLU, and SDC2. In the targeted regulation network of miRNA-mRNA, the hsa-miR-424-5p was found to synchronously modulate two hub genes. Survival analysis showed that patients with high expression of CLU and APOE had better prognosis.

Conclusions

CLU and APOE are involved in the molecular mechanism of papillary thyroid cancer. The hsa-miR-424-5p might have the potential to reverse the processes of papillary thyroid cancer by modulating the hub genes. These are potential targets for the treatment of patients with papillary thyroid cancer.

SUBMITTER: Nan BY 

PROVIDER: S-EPMC7817291 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

Comprehensive Identification of Potential Crucial Genes and miRNA-mRNA Regulatory Networks in Papillary Thyroid Cancer.

Nan Ben-Yu BY   Xiong Guo-Feng GF   Zhao Zi-Rui ZR   Gu Xi X   Huang Xin-Sheng XS  

BioMed research international 20210112


<h4>Background</h4>Thyroid cancer is the most common endocrine malignancy, with a recent global increase of 20% in age-related incidence. Ultrasonography and ultrasonography-guided fine-needle aspiration biopsy (FNAB) are the most widely used diagnostic tests for thyroid nodules; however, it is estimated that up to 25% of thyroid biopsies are cytologically inconclusive. Molecular markers can help guide patient-oriented and targeted treatment of thyroid nodules and thyroid cancer.<h4>Methods</h4>  ...[more]

Similar Datasets

| S-EPMC7417634 | biostudies-literature
| S-EPMC5021476 | biostudies-literature
| S-EPMC8228551 | biostudies-literature
| S-EPMC9300925 | biostudies-literature
| S-EPMC5727401 | biostudies-literature
| S-EPMC8149909 | biostudies-literature
| S-EPMC7647549 | biostudies-literature
| S-EPMC6754980 | biostudies-literature
| S-EPMC8561771 | biostudies-literature
| S-EPMC8487426 | biostudies-literature